ImCare Biotech, Inc.
Biotechnology company · Doylestown, Pennsylvania, United States
ImCare Biotech, Inc. is a biotechnology company headquartered in Doylestown, Pennsylvania, United States. It has received 5 US government small-business research awards (SBIR/STTR) from health agencies, $6.8 million in total, most recently in 2025. It has reported private securities offerings to the US SEC, most recently $153,402 sold in a notice filed in 2023.
ImCare Biotech at a glance
What does ImCare Biotech do?
US government research funding
5 SBIR/STTR small-business research awards from US health agencies, $6.8 million in total (2012 to 2025). NIH funding came from the National Cancer Institute.
Private fundraising reported to the SEC
5 Form D notices; the most recent reported $153,402 sold (2023).
Frequently asked questions about ImCare Biotech
Where is ImCare Biotech headquartered?
ImCare Biotech, Inc. is headquartered in Doylestown, Pennsylvania, United States.
What does ImCare Biotech do?
ImCare Biotech, Inc. is a biotechnology company.
Similar companies
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
- Vaxcyte, Inc.San Carlos, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.